|
|
 |
|
Viewing report
|
|
|
|
Stem Cell Market: Opportunities and Challenges
Koncept Analytics, Dec 2010, Pages: 44
Stem cell biology is a promising and emerging field of the life sciences. Advances in biological sciences and the development of human stem cells are bringing new hope for the treatment of many diseases such as Parkinson’s disease, diabetes, heart diseases and cancer as well as injuries for which there has previously been no effective treatment. The medical stem cells market is divided into three categories: stem cell therapeutics, cord blood banking and drug development tools based on the application. Stem cell therapeutics account for a major portion of the market which has been boosted by recent technological breakthroughs that expanded the scope of therapeutic uses. North America is the largest market for stem cells for 2009 with a share of slightly over one-third of global market while Europe is projected to be the second largest and second fastest growing market.
US is the major stem cell market in the world and has recently been boosted by the decision on lifting the 8 years old ban on federal funding for embryonic stem cell research on March 2009. Despite of the technological and ethical challenges surrounding the utilization of embryonic stem cells, recent developments to grow human embryonic stem cells in culture and an increased understanding of the pathways of cell differentiation have expanded the horizon of likely therapeutic uses. In addition, rising patient population, demand for umbilical cord cell banking and transplantation have increased the demand for stem cells development.
The current report covers the overview, market size and segmentation of the worldwide stem cell product market. The US market for stem cells is also discussed in detail. The various drivers and the challenges faced by the market are also discussed in detail. The competitive aspect of the market is also highlighted and the key players are profiled with their strategies for this market.
|
|
|
|
